Pulmonary hypertension associated with HIV infection - Pulmonary vascular disease: The global perspective

Chest

Volumn 137, Issue 6 SUPPL., 2010, Pages 6S-12S

  Almodovar, Sharilyn ^a   Cicalini, Stefania ^b   Petrosillo, Nicola ^b   Flores, Sonia C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; NEF PROTEIN; TRANSACTIVATOR PROTEIN;

AFRICA; CELLULAR IMMUNITY; COMORBIDITY; DEVELOPING COUNTRY; DISEASE MARKER; DISEASE REGISTRY; DYSPNEA; ECHOCARDIOGRAPHY; GENE MUTATION; GENE SEQUENCE; HEART CATHETERIZATION; HEMODYNAMICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MACROPHAGE; MIXED INFECTION; MONOCYTE; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SCREENING; SURVIVAL RATE;

EID: 77953306022     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-3065     Document Type: Review

References (49)

1. Degano B, Guillaume M, Savale L, et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS. 2010;24(1):67-75.
2. Zuber JP, Calmy A, Evison JM, et al; Swiss HIV Cohort Study Group. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis. 2004;38(8):1178-1185.
3. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organizations (WHO). AIDS Epidemic Update 2009. Geneva, Switzerland: WHO; 2009.
4. Lederman MM, Sereni D, Simonneau G, Voelkel NF. Pulmonary arterial hypertension and its association with HIV infection: an overview. AIDS. 2008;22(Suppl 3):S1-S6.
5. Cicalini S, Chinello P, Cicini MP, Petrosillo N. Pulmonary arterial hypertension and HIV infection. AIDS. 2008;22(16):2219-2220.
6. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest. 1991;100(5):1268-1271.
7. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med. 2008;177(1):108-113.
8. Opravil M, Sereni D. Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era. AIDS. 2008;22(Suppl 3):S35-S40.
9. Hsue PY, Deeks SG, Farah HH, et al. Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS. 2008;22(7):825-833. (Pubitemid 351563831)
10. Byers DK, Nayak G, Ferguson M. Prevalence of pulmonary hypertension in asymptomatic HIV-infected patients receiving antiretroviral therapy. Paper presented at: 48th Annual International Conference on Antimicrobial Agents and Chemotherapy (ICAAC); October 25-28, 2008; Washington DC.
11. Nunes H, Humbert M, Sitbon O, et al. Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2003;167(10):1433-1439.
12. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023-1030.
13. Pellicelli AM, Barbaro G, Palmieri F, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology. 2001;52(1):31-41. (Pubitemid 32113205)
14. Pellicelli AM, D'Ambrosio C, Vizza CD, et al. HIV-related pulmonary hypertension. From pathogenesis to clinical aspects. Acta Cardiol. 2004;59(3):323-330.
15. Reinsch N, Buhr C, Krings P, et al; Competence Network of Heart Failure. Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study. HIV Med. 2008;9(7):550-556.
16. Humbert M. Mediators involved in HIV-related pulmonary arterial hypertension. AIDS. 2008;22(Suppl 3):S41-S47.
17. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest. 2000;118(4):1133-1141.
18. Aliyu ZY, Kato GJ, Taylor J VI, et al. Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management. Am J Hematol. 2008;83(1):63-70.
19. Ntsekhe M, Hakim J. Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation. 2005;112(23):3602-3607.
20. Cool CD, Rai PR, Yeager ME, et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med. 2003;349(12):1113-1122.
21. Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med. 2009;6(2):120-127.
22. Humbert M, Monti G, Fartoukh M, et al. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J. 1998;11(3):554-559.
23. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol. 1994;144(2):275-285. (Pubitemid 24165948)
24. Dorfmüller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J. 2003;22(2):358-363.
25. Sehgal PB, Mukhopadhyay S. Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2007;37(1):31-37.
26. Smith P, Heath D. Electron microscopy of the plexiform lesion. Thorax. 1979;34(2):177-186.
27. Sehgal PB, Mukhopadhyay S, Patel K et al. Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol 2009;297(4):L729-L737.
28. Kanmogne GD, Primeaux C, Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol. 2005;64(6):498-505. (Pubitemid 40781152)
29. Mette SA, Palevsky HI, Pietra GG, et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis. 1992;145(5):1196-1200.
30. Lee SW, Lee YM, Bae SK, Murakami S, Yun Y, Kim KW. Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem Biophys Res Commun. 2000;268(2):456-461.
31. Montani D, Marcelin AG, Sitbon O, Calvez V, Simonneau G, Humbert M. Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France. AIDS. 2005;19(11):1239-1240.
32. Kim J, Ruff M, Karwatowska-Prokopczuk E, et al. HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis. Regul Pept. 1998;75-76:201-205.
33. Rusnati M, Presta M. HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis. 2002;5(3):141-151.
34. Caldwell RL, Gadipatti R, Lane KB, Shepherd VL. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. J Leukoc Biol. 2006;79(1):192-201.
35. Fackler OT, Lu X, Frost JA, et al. p21-Activated kinase 1 plays a critical role in cellular activation by Nef. Mol Cell Biol. 2000;20(7):2619- 2627.
36. Roeth JF, Collins KL. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev. 2006;70(2):548-563.
37. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med. 1994;179(1):101-113.
38. Lehmann MH, Walter S, Ylisastigui L, et al. Extracellular HIV-1 Nef increases migration of monocytes. Exp Cell Res. 2006;312(18):3659-3668.
39. Olivetta E, Percario Z, Fiorucci G, et al. HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol. 2003;170(4):1716-1727.
40. Capoccia BJ, Gregory AD, Link DC. Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion. J Leukoc Biol. 2008;84(3):760-768.
41. James CO, Huang MB, Khan M, Garcia-Barrio M, Powell MD, Bond VC. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol. 2004;78 (6): 3099-3109.
42. Marecki J, Cool C, Voelkel N, Luciw P, Flores S. Evidence for vascular remodeling in the lungs of macaques infected with simian immunodeficiency virus/HIV NEF recombinant virus. Chest. 2005;128(6 Suppl):621S-622S.
43. Marecki JC, Cool CD, Parr JE, et al. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med. 2006;174(4):437-445.
44. Acheampong EA, Parveen Z, Muthoga LW, Kalayeh M, Mukhtar M, Pomerantz RJ. Human immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J Virol. 2005;79(7):4257-4269.
45. Lenassi M, Cagney G, Liao M, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic. 2010;11(1):110-122.
46. Duffy P, Wang X, Lin PH, et al. HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res. 2009;156(2):257-264.
47. Mandell CP, Reyes RA, Cho K, et al. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques. Virology. 1999;265 (2): 235-251.
48. Almodovar S, Simonneau G., Humbert M, et al. Association between HIV-1 Nef signature sequences and HIV-related pulmonary hypertension. Poster presented at: American Thoracic Society International Conference; May 16-21, 2008; Toronto, Canada.
49. Petrosillo N, Chinello P, Cicalini S. Pulmonary hypertension in individuals with HIV infection. AIDS. 2006;20(16):2128-2129.